Additionally, a high expression of NUCB1, COPG1, CD44, ALDH18A1, IRF4, SCRN1, B2M, and PRMT1 mRNAs was associated with the worst overall survival (OS) for patients with DLBCL (Figure 4G–I and Figure S5A–L). This evidence concerns the gene CD44 and diffuse large B-cell lymphoma.